TBA Novo Nordisk Pharmaceuticals Pty Ltd

Denecimig is proposed to be used, on a regular basis, to prevent bleeding episodes in people with haemophilia A. Haemophilia A is a condition in which the blood does not clot properly because there is not enough blood clotting factor VIII. It is proposed that denecimig can be used in people of all ages, including those who have developed factor VIII inhibitors and those who have not.